𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Up-regulation of amphotrophic retroviral receptor expression in human peripheral blood CD34+ cells

✍ Scribed by Kaubisch, Andreas; Ward, Maureen; Schoetz, Stuti; Hesdorffer, Charles; Bank, Arthur


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
721 KB
Volume
61
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

✦ Synopsis


Retroviral-mediated gene transfer into hematopoietic stem cells provides the only means of stable transduction of these cells and their progeny for use with a variety of potentially therapeutic genes. Expression of the Moloney amphotropic retroviral receptor-pit-2 or GLVR-2-is critical to the recognition and entry of Moloney leukemia virus-derived viruses into human target cells such as CD34+ hematopoietic cells. GLVR-2 functions as a sodium-dependent phosphate transporter as well as a receptor. We have previously shown that the expression of the murine homologue of the amphotropic receptor Ram1, also a phosphate transporter, is developmentally regulated in murine hematopoietic fetal liver cells. We also demonstrated that culture of murine fetal liver cells in phosphate-free (PO 4 -free) medium increases levels of receptor mRNA and makes murine fetal liver cells susceptible to Moloney amphotropic viral gene transfer. We now examine the effect of culture conditions on the expression of GLVR-2 in human CD34+ cells. In this report, we demonstrate that there is a 2-3 fold increase in GLVR-2 mRNA levels in CD34+ cells after 3 days in culture with interleukin 3, interleukin 6, and stem-cell factor. In addition, the use of PO 4 -free medium increases expression of GLVR-2 an additional 2-fold in these cells during this time. These results indicate that GLVR-2 expression can be up-regulated on these cells, and may permit improved retroviral gene transfer efficiencies. Am. J. Hematol. 61:243-253, 1999.


πŸ“œ SIMILAR VOLUMES


Targeted transduction of CD34+ hematopoi
✍ Min Liang; Nonia Pariente; Kouki Morizono; Irvin S. Y. Chen πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 973 KB

## Abstract ## Background Conventional gene‐therapy applications of hematopoietic stem cells (HSCs) involve purification of CD34+ progenitor cells from the mobilized peripheral blood, __ex vivo__ transduction of the gene of interest into them, and reinfusion of the transduced CD34+ progenitor cell